Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Hadean Ventures

Investor type Private Equity Firm
Founders Ingrid Teigland Akay


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 21
Average round size
The average size of a deal this fund participated in
Portfolio companies 16
Rounds per year 2.33
Lead investments 2
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 3
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Clinical Trials

Hadean Ventures appeared to be the VC, which was created in 2014. The main department of described VC is located in the Oslo. The venture was found in Europe in Norway.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Hadean Ventures, startups are often financed by aws Gru00fcnderfonds (aws Founders Fund), Wellington Partners, Ventech. The meaningful sponsors for the fund in investment in the same round are aws Gru00fcnderfonds (aws Founders Fund), Wellington Partners, Versant Ventures.

The important activity for fund was in 2019. The fund is constantly included in 2-6 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund. Speaking about the real fund results, this VC is 30 percentage points more often commits exit comparing to other organizations.

Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups. For fund there is no match between the location of its establishment and the land of its numerous investments - Sweden. Among the most successful fund investment fields, there are Medical, B2B. Among the various public portfolio startups of the fund, we may underline Themis Bioscience, AttgeNO, SAGA Diagnostics

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Hadean Ventures:
Typical Co-investors
Hadean Ventures is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Hadean Ventures:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Axell Japan, Tokyo
Beacon Holding California, Los Angeles, United States
Chart Industries Ohio, Ohio City, United States
ForMED Ventures Taipei, Taiwan
Heartland Dental -
IMPACT Growth -
Industrial Bank China, Foochow, Fujian
Kyosemi Japan, Kyoto, Kyoto Prefecture
Responder Ventures Florida, United States, West Palm Beach
SDIC Unity Capital Beijing, Beijing, China
Seamless New York, New York, United States
Shuangliang Group -
The Scoular Company Nebraska, Omaha, United States
Trancos Ventures Illinois, Lincolnshire, United States
Viewpoint Investment Partners -
Walkabout Ventures California, Los Angeles, United States
Yamcom Holdings BV Afula, Israel, North District
Yunsheng Touzi China, Jinshan District

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

TargED Biopharmaceuticals

Health Care
$46M19 Feb 2022 Utrecht, Utrecht, The Netherlands

Ribbon Biolabs

$21M31 Jan 2022 Vienna, Austria

Emergence Therapeutics

Health Care
$102M07 Dec 2021 Duisburg, Nordrhein-Westfalen, Germany

Cardior Pharmaceuticals

$75M25 Aug 2021 Hanover, Lower Saxony, Germany


Life Science
$27M29 Jun 2021 Oslo, Norway

Step Pharma

$41M24 Mar 2021 Paris, Ile-de-France, France

Pipeline Therapeutics

$80M11 Feb 2021 San Diego, California, United States


Health Care
Health Diagnostics
$64M25 Sep 2020 Capital Region of Denmark


Health Care
Medical Device
$18M05 Aug 2020 Trøndelag
Cardior Raises €64M in Series B Funding

– Cardior Pharmaceuticals from Hanover develops non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases.
– The company closed a €64m ($76m) Series B financing round.
– The round was led by Inkef Capital, supported by fellow new investors Fund+, Sunstone, Hadean Ventures and Coparion with participation from existing investors including LSP, BioMedPartners, Bristol Myers Squibb and High-Tech Gründerfonds.
– The new investment will be used for the late-stage clinical development of its lead program and the expansion of its earlier-stage pipeline.

Step Pharma Raises EUR35 Million in Series B Financing to Advance First in Class CTPS1 inhibitor into the Clinic in T Cell Malignancies

– Step Pharma, a biotech company developing novel drugs for oncology and autoimmune diseases, today announced the successful closing of a EUR35 million Series B financing.
– New investors Hadean Ventures and Sunstone Life Science Ventures co-led the round, joining existing investors Kurma Partners, Pontifax and Bpifrance, which reinvested through its Innovative Biotherapies and Rare Diseases fund and InnoBio 2 fund.
– As part of the financing, Jacob L Moresco from Sunstone Life Science Ventures and Walter Stockinger from Hadean Ventures will join the Step Pharma Board of Directors.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Hadean Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: